Malignant Perivascular Epithelioid Cell Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2013-08-02
Clinical Trial Update: A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa [Phase 2]
The Phase II trial of BEZ235 (dactolisib) as monotherapy for malignant perivascular epithelioid cell tumor has been withdrawn.